Clinical Trial Update: Safety, PK, and Efficacy of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure With Reduced Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety, pharmacokinetics, and efficacy of omecamtiv mecarbil in Japanese patients with heart failure with reduced ejection fraction; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• omecamtiv mecarbil (omecamtiv mecarbil)

Snippet

Sponsor: Cytokinetics | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 2 | Status: COMPLETED | Results posted: 2020-01-31